Status:
NO_LONGER_AVAILABLE
ARCHIMEDES Compassionate Use Supplement
Lead Sponsor:
Cerenovus, Part of DePuy Synthes Products, Inc.
Conditions:
Pain
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this Compassionate Use Supplement to the IDE Protocol is to assure and monitor the safety of six Subjects (in the United States) implanted with ARCHIMEDES until all remaining implanted ...
Detailed Description
Pain management has been a long-standing challenge to the medical community, specifically the treatment of chronic pain. On October 3, 2002, FDA approved Codman's IDE Study of Codman's Implantable Con...
Eligibility Criteria
Inclusion
- U. S. Subjects implanted with constant flow pump in 2003.
Exclusion
- N/A
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00660556
Last Update
November 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Side Pain Solutions
Danville, Virginia, United States, 24541